Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Microbiol. 2009 Apr;7(4):263-73. doi: 10.1038/nrmicro2109.

Principles of c-di-GMP signalling in bacteria.

Author information

1
Institut für Biologie-Mikrobiologie, Freie Universität Berlin, 14195 Berlin, Germany. Rhenggea@zedat.fu-berlin.de

Abstract

On the stage of bacterial signal transduction and regulation, bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) has long played the part of Sleeping Beauty. c-di-GMP was first described in 1987, but only recently was it recognized that the enzymes that 'make and break' it are not only ubiquitous in the bacterial world, but are found in many species in huge numbers. As a key player in the decision between the motile planktonic and sedentary biofilm-associated bacterial 'lifestyles', c-di-GMP binds to an unprecedented range of effector components and controls diverse targets, including transcription, the activities of enzymes and larger cellular structures. This Review focuses on emerging principles of c-di-GMP signalling using selected systems in different bacteria as examples.

PMID:
19287449
DOI:
10.1038/nrmicro2109
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center